Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 1,670 | 6,462 | 7,803 | 7,047 | 4,146 |
| Operating Income | -1,670 | -6,462 | -7,803 | -7,047 | -4,146 |
| Interest Expense | 47 | 425 | 6 | 1,123 | 9 |
| Other Income | -378 | 2,024 | 2,442 | 29 | 172 |
| Pre-tax Income | -2,095 | -4,863 | -5,367 | -8,141 | -3,983 |
| Net Income Continuous | -2,095 | -4,863 | -5,367 | -8,141 | -3,983 |
| Net Income | $-2,095 | $-4,863 | $-5,367 | $-8,141 | $-3,983 |
| EPS Basic Total Ops | -3,672.80 | -48,271.06 | -0.82 | -1.46 | -0.04 |
| EPS Basic Continuous Ops | -3,659.81 | -47,997.46 | -0.83 | -1.45 | -0.87 |
| EPS Diluted Total Ops | -3,672.80 | -48,271.06 | -0.82 | -1.46 | -0.04 |
| EPS Diluted Continuous Ops | -3,659.81 | -47,997.46 | -0.83 | -1.45 | -0.87 |
| EPS Diluted Before Non-Recurring Items | -32,110.75 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,566 | $-6,337 | $-7,681 | $-6,940 | $-4,055 |